Healthcare, Regulatory and Reimbursement Landscape - India
Summary
GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - India". The report is an essential source of information and analysis on India's healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.
India is the second most populated country in the world with a population of approximately 1.21 billion in 2011, although the growth rate of the population is declining due to a decrease in the birth rate and an increase in net emigration. Unlike China and Japan, the working-age population accounts for the majority of the overall population. In order to derive maximum benefit, the government is currently working to develop human capital by increasing its spending on health and education. The country's pharmaceutical market was valued at $12.9 billion in 2010 and is expected to reach approximately $54 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 15.4%, primarily attributed to - - Increasing coverage of healthcare insurance- Improving access to healthcare facilities- Government initiatives for the prevention and management of communicable diseases
Scope
The report provides information on India's healthcare, regulatory and reimbursement landscape, and includes - - Overview of the pharmaceutical and medical devices markets, comprising market size, segmentation and key drivers and barriers- Profiles and SWOT analysis of the major players in the pharmaceutical and medical devices market. The major players covered for the pharmaceutical market are Cipla, Sun Pharmaceuticals, Lupin, Ranbaxy Laboratories and Dr. Reddy's Laboratories. The major players covered for the medical devices market are Siemens Healthcare, GE Healthcare, Hindustan Syringes and Medical Devices, Essilor International and F. Hoffmann-La Roche.- Insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs- Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure- Overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to - - Develop business strategies by understanding the trends shaping and driving India's healthcare market- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Indian healthcare market in the future- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership- Identify, understand and capitalize on the opportunities and challenges in India's healthcare market1 Table of Contents1 Table of Contents 51.1 List of Tables 71.2 List of Figures 92 Introduction 112.1 Report Guidance 113 Overview of the Pharmaceutical and Medical Device Market 123.1 Pharmaceutical Market 123.1.1 Market Overview 123.1.2 Supply Channels 163.1.3 Market Segments 193.1.4 Major Therapeutic Areas 243.1.5 Major Players 273.2 Medical Device Market 493.2.1 Market Overview 493.2.2 Overview of Top Five Segments 513.2.3 Major Players 623.3 Market Drivers and Barriers 783.3.1 Drivers 783.3.2 Barriers 784 Market Access 814.1 Reimbursement and Payer Landscape 814.1.1 Overview of Healthcare System 814.1.2 Reimbursement Process 844.1.3 Overview of Insurance Providers 914.1.4 Patient Share of Healthcare Spending 934.1.5 Drug Price Trends 944.1.6 Pricing Policies 954.2 Regulatory Landscape 964.2.1 Overview of Regulatory Agencies 964.2.2 New Drug Approval Procedure for Pharmaceutical Products 974.2.3 New Medical Device Approval Process 1004.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 1014.2.5 Licensing Process for Pharmaceutical Exports and Imports 1024.2.6 Intellectual Property Rights 1034.2.7 Clinical Trial Regulations 1064.2.8 Pharmaceutical Advertising Regulations 1084.2.9 Pharmacy Regulations 1084.2.10 Labeling and Packaging Regulations 1095 Country Analysis 1105.1 Political Environment 1105.1.1 Political Structure 1105.1.2 Analysis of the Current Political Environment 1105.1.3 Healthcare Policy Initiatives 1125.2 Economic Landscape 1135.3 Economic Indicators 1165.3.1 Gross Domestic Product 1165.3.2 Gross National Income 1205.3.3 Inflation 1215.3.4 Currency Exchange Rate 1255.3.5 Foreign Direct Investment 1265.3.6 Foreign Exchange Reserves 1275.3.7 Trade Balance 1285.3.8 Gross Fiscal Deficit 1305.3.9 External Gross Debt 1315.3.10 Major Industries 1325.4 Demographics 1345.4.1 Population 1345.4.2 Education and Literacy 1485.4.3 Employment 1505.4.4 Disease Burden 1515.5 Healthcare Infrastructure 1535.5.1 Healthcare Facilities 1535.5.2 Healthcare Parameters 1605.5.3 Environmental Health 1625.5.4 Healthcare Personnel 1665.6 Healthcare Expenditure 1685.6.1 Components of Healthcare Spending 1695.6.2 Pharmaceutical Expenditure 1715.6.3 Share of Public and Private Sectors 1725.6.4 Spending in Pharmaceutical R&D 1735.7 Trade Associations 1745.7.1 Indian Pharmaceutical Association 1745.7.2 Indian Drug Manufacturer's Association 1745.7.3 Organization of Pharmaceutical Producers of India 1745.7.4 Indian Pharmacy Graduates Association 1745.8 Trade Fairs 1756 Opportunities and Challenges 1766.1 Opportunities 1766.2 Challenges 1777 Appendix 1807.1 Abbreviations 1807.2 Bibliography 1837.3 Methodology 1887.3.1 Coverage 1887.3.2 Secondary Research 1897.3.3 Forecasting 1897.3.4 Primary Research 1897.3.5 Expert Panel Validation 1897.4 Contact Us 1907.5 Disclaimer 190
List of Tables
Table 1: Pharmaceutical Market ($bn), India, 20052010 14Table 2: Pharmaceutical Market ($bn), India, Forecast, 20112020 15Table 3: Price Margins of Distribution Channel (%), India, 2007 17Table 4: Drugs Going Off-patent, Revenue ($bn), Global, 20112014 20Table 5: Biologics Market ($bn), India, 20052010 22Table 6: Biologics Market, India, Segment Share (%), 2010 23Table 7: Major Therapeutic Areas, India, Revenue ($m), 2008 24Table 8: Major Pharmaceutical Companies, India, Revenue ($m), 2011 27Table 9: Major Products, Cipla, 2010 28Table 10: Production, Major Products Categories, Cipla, 2010 29Table 11: Major Product Segments, Sun Pharma, Revenues ($m), Global, 2010 32Table 12: Major Products, Lupin, India, 2010 37Table 13: Major Products, Dr. Reddy's Laboratories, India, Revenue ($m), 2010 45Table 14: Medical Device Market ($bn), India, 20062011 49Table 15: Medical Device Market ($bn), India, Forecast, 20122020 50Table 16: Medical Device Market, India, Segments, Revenue ($m), 2011 51Table 17: Ophthalmic Devices Market ($m), India, 20062011 52Table 18: Sales Trend for Major Players*, Ophthalmic Devices, India, 2010 53Table 19: Hospital Supplies Market ($m), India, 20062011 54Table 20: Sales Trend for Major Players*, Hospital Supplies, India, 2010 55Table 21: Diagnostic Imaging Devices Market ($m), India, 20062011 56Table 22: Sales Trend for Major Players*, Diagnostic Imaging Devices, India, 2010 57Table 23: In Vitro Diagnostics Market ($m), India, 20062011 58Table 24: Sales Trend for Major Players*, In Vitro Diagnostic Devices, India, 2010 59Table 25: Cardiovascular Devices Market ($m), India, 20062011 60Table 26: Sales Trend for Major Players*, Cardiovascular Devices, India, 2010 61Table 27: Major Medical Device Companies, India, Revenue ($m), 2010 62Table 28: Major Products, Siemens, Global, Revenue ($m), 2010 63Table 29: Major Products, Essilor, Global, Revenue ($m), 2010 72Table 30: Major Products, Roche, Global, Revenue ($m), 2010 75Table 31: Surgical Procedure Cost ($'000s), 2011 83Table 32: Major Public Insurance Schemes, India, 2011 91Table 33: Insured Population, India, Share (m), 2010 91Table 34: Health Insurers, Accounts ($m), India, 2010 92Table 35: Healthcare Spending, India, Patient's Share (%), 20052010 93Table 36: Drug Price Change (%), India, 20052010 94Table 37: Specific Requirements, New Drug Application, India, 2011 98Table 38: Specific Requirements, Clinical Trial Approval, India, 2011 106Table 39: Impact of Union Budget on Healthcare Sector, India, 20122013 112Table 40: Major Sectors, India, GDP Growth (%), 20112012 114Table 41: GDP Per Capita ($), India, 20052010 116Table 42: GDP Per Capita ($), India, Forecast, 20112020 117Table 43: GDP, India, Annual Growth (%), 20062011 118Table 44: GDP, India, Annual Growth (%), Forecast, 20122020 119Table 45: GNI Per Capita ($), India, 20052010 120Table 46: Average Consumer Price Index, India, 20062011 121Table 47: Average Consumer Price Index, India, Forecast, 20122020 122Table 48: Average Consumer Price, India, Annual Change (%), 20062011 123Table 49: Average Consumer Price, India, Annual Change (%), Forecast, 20122020 124Table 50: Currency Exchange Rate (INR/$), India, 20062011 125Table 51: Foreign Direct Investment ($bn), India, 20052010 126Table 52: Foreign Exchange Reserves ($bn), India, 20052010 127Table 53: Imports of Goods and Services ($bn), India, 20052010 128Table 54: Exports of Goods and Services ($bn), India, 20052010 129Table 55: Gross Fiscal Deficits (% of GDP), India, 20052010 130Table 56: External Government Gross Debt ($bn), India, 20052010 131Table 57: Major Industries, India, GDP ($bn), 2010 133Table 58: Population (m), India, 20062011 134Table 59: Population (m), India, Forecast, 20122020 135Table 60: Urban and Rural Population, India, Share (%), 20062011 136Table 61: Age Groups, India, Population Distribution (%), 20062011 137Table 62: Age Groups, India, Population Distribution (%), Forecast, 20122020 138Table 63: Births (Per 1,000 Population), India, 20052010 139Table 64: Mortality (Per 1,000 Population), India, 20052010 140Table 65: Major Causes of Mortality ('000s), India, 2008 141Table 66: Children <5 Years, India, Mortality Rate (Per 1,000 Live Births), 20052010 142>Table 67: Immunization Rate (%), India, 20052010 143Table 68: Major Causes of Male Mortality ('000s), India, 2008 144Table 69: Major Causes of Female Mortality ('000s), India, 2008 145Table 70: Gender Ratio (Females Per 1,000 Males), India, 20062011 146Table 71: Life Expectancy at Birth (Years), India, 20052010 147Table 72: Literacy Rate (%), India, 20062011 148Table 73: Levels of Education, India, Students Enrollment (m), 2009 149Table 74: Employees, India, Segment Share (%), 2010 150Table 75: Major Communicable Diseases, Prevalence (Per 100,000 Population), India, 2010 151Table 76: Major Diseases, India, DALY (Per 100,000 Population), 2004 152Table 77: Public Hospitals, India, 20052010 153Table 78: Major Private Hospitals, India, 2012 154Table 79: Upcoming Health Cities, India, 2012 155Table 80: Health Centers ('000s), India, 20052010 156Table 81: Hospitals by Bed Size, India, Share (%), 2010 157Table 82: Public Hospital Beds ('000s), India, UrbanRural, 20052010 158Table 83: Diagnostic Units (Per 100,000 Population), 2008 159Table 84: Beds (Per 1,000 Population), India, 20052010 160Table 85: Physicians (Per 100,000 Population), India, 20052010 161Table 86: CO2 Emission (MMt), India, 20052010 162Table 87: PM-10 Emissions (ตgm/cubic meter), India 20052010 163Table 88: Waste Generation Per Capita (kg), India, 20052010 164Table 89: Composition of Municipal Solid Waste (%), India, 2005 165Table 90: Nurses (Per 100,000 Population), India, 20052010 166Table 91: Pharmacists (Per 100,000 Population), India, 20052010 167Table 92: Healthcare Expenditure (% of GDP), India, 20052010 168Table 93: Healthcare Expenditure, India, Share of Major Components (%), 2005 169Table 94: Healthcare Expenditure of Ministry of Health and Family Welfare, India, Share of Departments (%), 2008 170Table 95: Pharmaceutical Expenditure (% of Total Healthcare Expenditure), India, 20052010 171Table 96: Healthcare Expenditure, India, Share (%), 20052010 172Table 97: R&D Expenditure ($m), India, 20052010 173Table 98: Major Healthcare Trade Fairs, India, 2012 175
List of Figures
Figure 1: Pharmaceutical Market ($bn), India, 20052010 14Figure 2: Pharmaceutical Market ($bn), India, Forecast, 20112020 15Figure 3: Distribution Channels, India, 2011 17Figure 4: Drug Procurement System in Government Hospitals and Institutions, India, 2011 18Figure 5: Biologics Market ($bn), India, 20052010 22Figure 6: Biologics Market, India, Segment Share (%), 2010 23Figure 7: Major Therapeutic Areas, India, Revenue ($m), 2008 24Figure 8: Major Pharmaceutical Companies, India, Revenue ($m), 2011 27Figure 9: Medical Device Market ($bn), India, 20062011 49Figure 10: Medical Device Market ($bn), India, Forecast, 20122020 50Figure 11: Medical Device Market, India, Segments, Revenue ($m), 2011 51Figure 12: Ophthalmic Devices Market ($m), India, 20062011 52Figure 13: Sales Trend for Major Players*, Ophthalmic Devices, India, 20062010 53Figure 14: Hospital Supplies Market ($m), India, 20062011 54Figure 15: Sales Trend for Major Players*, Hospital Supplies, India, 20062010 55Figure 16: Diagnostic Imaging Devices Market ($m), India, 20062011 56Figure 17: Sales Trend for Major Players*, Diagnostic Imaging Devices, India, 20062010 57Figure 18: In Vitro Diagnostics Market ($m), India, 20062011 58Figure 19: Sales Trend for Major Players*, In Vitro Diagnostic Devices, India, 20062010 59Figure 20: Cardiovascular Devices Market ($m), India, 20062011 60Figure 21: Sales Trend for Major Players*, Cardiovascular Devices, India, 20062010 61Figure 22: Major Medical Device Companies, India, Revenue ($m), 2010 62Figure 23: Drivers and Barriers, Healthcare Market, India, 2011 80Figure 24: Milestones of the Insurance Regulatory System, India, 19382009 82Figure 25: Surgical Procedure Cost ($'000s), 2011 83Figure 26: Local Purchase System, Private Hospitals, India, 2012 85Figure 27: Centralized Purchase System, Private Hospitals, India, 2012 86Figure 28: Tender Purchase System, Private Hospitals, India, 2012 87Figure 29: Local and Centralized Purchase System, Private Hospitals, India, 2012 88Figure 30: Purchase Channels, Private Hospitals, India, 2012 89Figure 31: Addition to a Hospital Drug Formulary, India, 2011 90Figure 32: Healthcare Spending, India, Patient's Share (%), 20052010 93Figure 33: Drug Price Change (%), India, 20052010 94Figure 34: Structure of the Central Drugs Standard Control Organization, India, 2011 96Figure 35: New Drug Application Process, India, 2011 99Figure 36: Licensing Process for Manufacturing, India, 2011 101Figure 37: Organizational Structure of the Controller General of Patents, Designs and Trade Marks, India, 2011 103Figure 38: Patent Approval Process, India, 2011 104Figure 39: Trademark Registration Process, India, 2011 105Figure 40: Clinical Trial Approval Process, India, 2011 107Figure 41: GDP Per Capita ($), India, 20052010 116Figure 42: GDP Per Capita ($), India, Forecast, 20112020 117Figure 43: GDP, India, Annual Growth (%), 20062011 118Figure 44: GDP, India, Annual Growth (%), Forecast, 20122020 119Figure 45: GNI Per Capita ($), India, 20052010 120Figure 46: Average Consumer Price Index, India, 20062011 121Figure 47: Average Consumer Price Index, India, Forecast, 20122020 122Figure 48: Average Consumer Price, India, Annual Change (%), 20062011 123Figure 49: Average Consumer Price, India, Annual Change (%), Forecast, 20122020 124Figure 50: Currency Exchange Rate (INR/$), India, 20062011 125Figure 51: Foreign Direct Investment ($bn), India, 20052010 126Figure 52: Foreign Exchange Reserves ($bn), India, 20052010 127Figure 53: Imports of Goods and Services ($bn), India, 20052010 128Figure 54: Exports of Goods and Services ($bn), India, 20052010 129Figure 55: Gross Fiscal Deficits (% of GDP), India, 20052010 130Figure 56: External Government Gross Debt ($bn), India, 20052010 131Figure 57: Major Industries, India, GDP ($bn), 2010 133Figure 58: Population (m), India, 20062011 134Figure 59: Population (m), India, Forecast, 20122020 135Figure 60: Urban and Rural Population, India, Share (%), 20062011 136Figure 61: Age Groups, India, Population Distribution (%), 20062011 137Figure 62: Age Groups, India, Population Distribution (%), Forecast, 20122020 138Figure 63: Births (Per 1,000 Population), India, 20052010 139Figure 64: Mortality (Per 1,000 Population), India, 20052010 140Figure 65: Major Causes of Mortality ('000s), India, 2008 141Figure 66: Children <5 Years, India, Mortality Rate (Per 1,000 Live Births), 20052010 142>Figure 67: Immunization Rate (%), India, 20052010 143Figure 68: Major Causes of Male Mortality ('000s), India, 2008 144Figure 69: Major Causes of Female Mortality ('000s), India, 2008 145Figure 70: Gender Ratio (Females Per 1,000 Males), India, 20062011 146Figure 71: Life Expectancy at Birth (Years), India, 20052010 147Figure 72: Literacy Rate (%), India, 20062011 148Figure 73: Levels of Education, India, Students Enrollment (m), 2009 149Figure 74: Employees, India, Segment Share (%), 2010 150Figure 75: Major Communicable Diseases, Prevalence (Per 100,000 Population), India, 2010 151Figure 76: Major Diseases, India, DALY (Per 100,000 Population), 2004 152Figure 77: Public Hospitals, India, 20052010 153Figure 78: Health Centers ('000s), India, 20052010 156Figure 79: Hospitals by Bed Size, India, Share (%), 2010 157Figure 80: Public Hospital Beds ('000s), India, UrbanRural, 20052010 158Figure 81: Diagnostic Units (Per 100,000 Population), 2008 159Figure 82: Beds (Per 1,000 Population), India, 20052010 160Figure 83: Physicians (Per 100,000 Population), India, 20052010 161Figure 84: CO2 Emission (MMt), India, 20052010 162Figure 85: PM-10 Emissions (ตgm/cubic meter), India 20052010 163Figure 86: Waste Generation Per Capita (kg), India, 20052010 164Figure 87: Composition of Municipal Solid Waste (%), India, 2005 165Figure 88: Nurses (Per 100,000 Population), India, 20052010 166Figure 89: Pharmacists (Per 100,000 Population), India, 20052010 167Figure 90: Healthcare Expenditure (% of GDP), India, 20052010 168Figure 91: Healthcare Expenditure, India, Share of Major Components (%), 2005 169Figure 92: Healthcare Expenditure of Ministry of Health and Family Welfare, India, Share of Departments (%), 2008 170Figure 93: Pharmaceutical Expenditure (% of Total Healthcare Expenditure), India, 20052010 171Figure 94: Healthcare Expenditure, India, Share (%), 20052010 172Figure 95: R&D Expenditure ($m), India, 20052010 173Figure 96: Opportunities and Challenges, Healthcare Market, India, 2011 179
To order this report: Diagnostics Industry: Healthcare, Regulatory and Reimbursement Landscape - India
__________________________Contact Nicolas: [email protected] US: (805)-652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
Advertisement
Summary
GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - India". The report is an essential source of information and analysis on India's healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.
Advertisement
India is the second most populated country in the world with a population of approximately 1.21 billion in 2011, although the growth rate of the population is declining due to a decrease in the birth rate and an increase in net emigration. Unlike China and Japan, the working-age population accounts for the majority of the overall population. In order to derive maximum benefit, the government is currently working to develop human capital by increasing its spending on health and education. The country's pharmaceutical market was valued at $12.9 billion in 2010 and is expected to reach approximately $54 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 15.4%, primarily attributed to - - Increasing coverage of healthcare insurance- Improving access to healthcare facilities- Government initiatives for the prevention and management of communicable diseases
Scope
The report provides information on India's healthcare, regulatory and reimbursement landscape, and includes - - Overview of the pharmaceutical and medical devices markets, comprising market size, segmentation and key drivers and barriers- Profiles and SWOT analysis of the major players in the pharmaceutical and medical devices market. The major players covered for the pharmaceutical market are Cipla, Sun Pharmaceuticals, Lupin, Ranbaxy Laboratories and Dr. Reddy's Laboratories. The major players covered for the medical devices market are Siemens Healthcare, GE Healthcare, Hindustan Syringes and Medical Devices, Essilor International and F. Hoffmann-La Roche.- Insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs- Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure- Overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to - - Develop business strategies by understanding the trends shaping and driving India's healthcare market- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Indian healthcare market in the future- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership- Identify, understand and capitalize on the opportunities and challenges in India's healthcare market1 Table of Contents1 Table of Contents 51.1 List of Tables 71.2 List of Figures 92 Introduction 112.1 Report Guidance 113 Overview of the Pharmaceutical and Medical Device Market 123.1 Pharmaceutical Market 123.1.1 Market Overview 123.1.2 Supply Channels 163.1.3 Market Segments 193.1.4 Major Therapeutic Areas 243.1.5 Major Players 273.2 Medical Device Market 493.2.1 Market Overview 493.2.2 Overview of Top Five Segments 513.2.3 Major Players 623.3 Market Drivers and Barriers 783.3.1 Drivers 783.3.2 Barriers 784 Market Access 814.1 Reimbursement and Payer Landscape 814.1.1 Overview of Healthcare System 814.1.2 Reimbursement Process 844.1.3 Overview of Insurance Providers 914.1.4 Patient Share of Healthcare Spending 934.1.5 Drug Price Trends 944.1.6 Pricing Policies 954.2 Regulatory Landscape 964.2.1 Overview of Regulatory Agencies 964.2.2 New Drug Approval Procedure for Pharmaceutical Products 974.2.3 New Medical Device Approval Process 1004.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 1014.2.5 Licensing Process for Pharmaceutical Exports and Imports 1024.2.6 Intellectual Property Rights 1034.2.7 Clinical Trial Regulations 1064.2.8 Pharmaceutical Advertising Regulations 1084.2.9 Pharmacy Regulations 1084.2.10 Labeling and Packaging Regulations 1095 Country Analysis 1105.1 Political Environment 1105.1.1 Political Structure 1105.1.2 Analysis of the Current Political Environment 1105.1.3 Healthcare Policy Initiatives 1125.2 Economic Landscape 1135.3 Economic Indicators 1165.3.1 Gross Domestic Product 1165.3.2 Gross National Income 1205.3.3 Inflation 1215.3.4 Currency Exchange Rate 1255.3.5 Foreign Direct Investment 1265.3.6 Foreign Exchange Reserves 1275.3.7 Trade Balance 1285.3.8 Gross Fiscal Deficit 1305.3.9 External Gross Debt 1315.3.10 Major Industries 1325.4 Demographics 1345.4.1 Population 1345.4.2 Education and Literacy 1485.4.3 Employment 1505.4.4 Disease Burden 1515.5 Healthcare Infrastructure 1535.5.1 Healthcare Facilities 1535.5.2 Healthcare Parameters 1605.5.3 Environmental Health 1625.5.4 Healthcare Personnel 1665.6 Healthcare Expenditure 1685.6.1 Components of Healthcare Spending 1695.6.2 Pharmaceutical Expenditure 1715.6.3 Share of Public and Private Sectors 1725.6.4 Spending in Pharmaceutical R&D 1735.7 Trade Associations 1745.7.1 Indian Pharmaceutical Association 1745.7.2 Indian Drug Manufacturer's Association 1745.7.3 Organization of Pharmaceutical Producers of India 1745.7.4 Indian Pharmacy Graduates Association 1745.8 Trade Fairs 1756 Opportunities and Challenges 1766.1 Opportunities 1766.2 Challenges 1777 Appendix 1807.1 Abbreviations 1807.2 Bibliography 1837.3 Methodology 1887.3.1 Coverage 1887.3.2 Secondary Research 1897.3.3 Forecasting 1897.3.4 Primary Research 1897.3.5 Expert Panel Validation 1897.4 Contact Us 1907.5 Disclaimer 190
List of Tables
Table 1: Pharmaceutical Market ($bn), India, 20052010 14Table 2: Pharmaceutical Market ($bn), India, Forecast, 20112020 15Table 3: Price Margins of Distribution Channel (%), India, 2007 17Table 4: Drugs Going Off-patent, Revenue ($bn), Global, 20112014 20Table 5: Biologics Market ($bn), India, 20052010 22Table 6: Biologics Market, India, Segment Share (%), 2010 23Table 7: Major Therapeutic Areas, India, Revenue ($m), 2008 24Table 8: Major Pharmaceutical Companies, India, Revenue ($m), 2011 27Table 9: Major Products, Cipla, 2010 28Table 10: Production, Major Products Categories, Cipla, 2010 29Table 11: Major Product Segments, Sun Pharma, Revenues ($m), Global, 2010 32Table 12: Major Products, Lupin, India, 2010 37Table 13: Major Products, Dr. Reddy's Laboratories, India, Revenue ($m), 2010 45Table 14: Medical Device Market ($bn), India, 20062011 49Table 15: Medical Device Market ($bn), India, Forecast, 20122020 50Table 16: Medical Device Market, India, Segments, Revenue ($m), 2011 51Table 17: Ophthalmic Devices Market ($m), India, 20062011 52Table 18: Sales Trend for Major Players*, Ophthalmic Devices, India, 2010 53Table 19: Hospital Supplies Market ($m), India, 20062011 54Table 20: Sales Trend for Major Players*, Hospital Supplies, India, 2010 55Table 21: Diagnostic Imaging Devices Market ($m), India, 20062011 56Table 22: Sales Trend for Major Players*, Diagnostic Imaging Devices, India, 2010 57Table 23: In Vitro Diagnostics Market ($m), India, 20062011 58Table 24: Sales Trend for Major Players*, In Vitro Diagnostic Devices, India, 2010 59Table 25: Cardiovascular Devices Market ($m), India, 20062011 60Table 26: Sales Trend for Major Players*, Cardiovascular Devices, India, 2010 61Table 27: Major Medical Device Companies, India, Revenue ($m), 2010 62Table 28: Major Products, Siemens, Global, Revenue ($m), 2010 63Table 29: Major Products, Essilor, Global, Revenue ($m), 2010 72Table 30: Major Products, Roche, Global, Revenue ($m), 2010 75Table 31: Surgical Procedure Cost ($'000s), 2011 83Table 32: Major Public Insurance Schemes, India, 2011 91Table 33: Insured Population, India, Share (m), 2010 91Table 34: Health Insurers, Accounts ($m), India, 2010 92Table 35: Healthcare Spending, India, Patient's Share (%), 20052010 93Table 36: Drug Price Change (%), India, 20052010 94Table 37: Specific Requirements, New Drug Application, India, 2011 98Table 38: Specific Requirements, Clinical Trial Approval, India, 2011 106Table 39: Impact of Union Budget on Healthcare Sector, India, 20122013 112Table 40: Major Sectors, India, GDP Growth (%), 20112012 114Table 41: GDP Per Capita ($), India, 20052010 116Table 42: GDP Per Capita ($), India, Forecast, 20112020 117Table 43: GDP, India, Annual Growth (%), 20062011 118Table 44: GDP, India, Annual Growth (%), Forecast, 20122020 119Table 45: GNI Per Capita ($), India, 20052010 120Table 46: Average Consumer Price Index, India, 20062011 121Table 47: Average Consumer Price Index, India, Forecast, 20122020 122Table 48: Average Consumer Price, India, Annual Change (%), 20062011 123Table 49: Average Consumer Price, India, Annual Change (%), Forecast, 20122020 124Table 50: Currency Exchange Rate (INR/$), India, 20062011 125Table 51: Foreign Direct Investment ($bn), India, 20052010 126Table 52: Foreign Exchange Reserves ($bn), India, 20052010 127Table 53: Imports of Goods and Services ($bn), India, 20052010 128Table 54: Exports of Goods and Services ($bn), India, 20052010 129Table 55: Gross Fiscal Deficits (% of GDP), India, 20052010 130Table 56: External Government Gross Debt ($bn), India, 20052010 131Table 57: Major Industries, India, GDP ($bn), 2010 133Table 58: Population (m), India, 20062011 134Table 59: Population (m), India, Forecast, 20122020 135Table 60: Urban and Rural Population, India, Share (%), 20062011 136Table 61: Age Groups, India, Population Distribution (%), 20062011 137Table 62: Age Groups, India, Population Distribution (%), Forecast, 20122020 138Table 63: Births (Per 1,000 Population), India, 20052010 139Table 64: Mortality (Per 1,000 Population), India, 20052010 140Table 65: Major Causes of Mortality ('000s), India, 2008 141Table 66: Children <5 Years, India, Mortality Rate (Per 1,000 Live Births), 20052010 142>Table 67: Immunization Rate (%), India, 20052010 143Table 68: Major Causes of Male Mortality ('000s), India, 2008 144Table 69: Major Causes of Female Mortality ('000s), India, 2008 145Table 70: Gender Ratio (Females Per 1,000 Males), India, 20062011 146Table 71: Life Expectancy at Birth (Years), India, 20052010 147Table 72: Literacy Rate (%), India, 20062011 148Table 73: Levels of Education, India, Students Enrollment (m), 2009 149Table 74: Employees, India, Segment Share (%), 2010 150Table 75: Major Communicable Diseases, Prevalence (Per 100,000 Population), India, 2010 151Table 76: Major Diseases, India, DALY (Per 100,000 Population), 2004 152Table 77: Public Hospitals, India, 20052010 153Table 78: Major Private Hospitals, India, 2012 154Table 79: Upcoming Health Cities, India, 2012 155Table 80: Health Centers ('000s), India, 20052010 156Table 81: Hospitals by Bed Size, India, Share (%), 2010 157Table 82: Public Hospital Beds ('000s), India, UrbanRural, 20052010 158Table 83: Diagnostic Units (Per 100,000 Population), 2008 159Table 84: Beds (Per 1,000 Population), India, 20052010 160Table 85: Physicians (Per 100,000 Population), India, 20052010 161Table 86: CO2 Emission (MMt), India, 20052010 162Table 87: PM-10 Emissions (ตgm/cubic meter), India 20052010 163Table 88: Waste Generation Per Capita (kg), India, 20052010 164Table 89: Composition of Municipal Solid Waste (%), India, 2005 165Table 90: Nurses (Per 100,000 Population), India, 20052010 166Table 91: Pharmacists (Per 100,000 Population), India, 20052010 167Table 92: Healthcare Expenditure (% of GDP), India, 20052010 168Table 93: Healthcare Expenditure, India, Share of Major Components (%), 2005 169Table 94: Healthcare Expenditure of Ministry of Health and Family Welfare, India, Share of Departments (%), 2008 170Table 95: Pharmaceutical Expenditure (% of Total Healthcare Expenditure), India, 20052010 171Table 96: Healthcare Expenditure, India, Share (%), 20052010 172Table 97: R&D Expenditure ($m), India, 20052010 173Table 98: Major Healthcare Trade Fairs, India, 2012 175
List of Figures
Figure 1: Pharmaceutical Market ($bn), India, 20052010 14Figure 2: Pharmaceutical Market ($bn), India, Forecast, 20112020 15Figure 3: Distribution Channels, India, 2011 17Figure 4: Drug Procurement System in Government Hospitals and Institutions, India, 2011 18Figure 5: Biologics Market ($bn), India, 20052010 22Figure 6: Biologics Market, India, Segment Share (%), 2010 23Figure 7: Major Therapeutic Areas, India, Revenue ($m), 2008 24Figure 8: Major Pharmaceutical Companies, India, Revenue ($m), 2011 27Figure 9: Medical Device Market ($bn), India, 20062011 49Figure 10: Medical Device Market ($bn), India, Forecast, 20122020 50Figure 11: Medical Device Market, India, Segments, Revenue ($m), 2011 51Figure 12: Ophthalmic Devices Market ($m), India, 20062011 52Figure 13: Sales Trend for Major Players*, Ophthalmic Devices, India, 20062010 53Figure 14: Hospital Supplies Market ($m), India, 20062011 54Figure 15: Sales Trend for Major Players*, Hospital Supplies, India, 20062010 55Figure 16: Diagnostic Imaging Devices Market ($m), India, 20062011 56Figure 17: Sales Trend for Major Players*, Diagnostic Imaging Devices, India, 20062010 57Figure 18: In Vitro Diagnostics Market ($m), India, 20062011 58Figure 19: Sales Trend for Major Players*, In Vitro Diagnostic Devices, India, 20062010 59Figure 20: Cardiovascular Devices Market ($m), India, 20062011 60Figure 21: Sales Trend for Major Players*, Cardiovascular Devices, India, 20062010 61Figure 22: Major Medical Device Companies, India, Revenue ($m), 2010 62Figure 23: Drivers and Barriers, Healthcare Market, India, 2011 80Figure 24: Milestones of the Insurance Regulatory System, India, 19382009 82Figure 25: Surgical Procedure Cost ($'000s), 2011 83Figure 26: Local Purchase System, Private Hospitals, India, 2012 85Figure 27: Centralized Purchase System, Private Hospitals, India, 2012 86Figure 28: Tender Purchase System, Private Hospitals, India, 2012 87Figure 29: Local and Centralized Purchase System, Private Hospitals, India, 2012 88Figure 30: Purchase Channels, Private Hospitals, India, 2012 89Figure 31: Addition to a Hospital Drug Formulary, India, 2011 90Figure 32: Healthcare Spending, India, Patient's Share (%), 20052010 93Figure 33: Drug Price Change (%), India, 20052010 94Figure 34: Structure of the Central Drugs Standard Control Organization, India, 2011 96Figure 35: New Drug Application Process, India, 2011 99Figure 36: Licensing Process for Manufacturing, India, 2011 101Figure 37: Organizational Structure of the Controller General of Patents, Designs and Trade Marks, India, 2011 103Figure 38: Patent Approval Process, India, 2011 104Figure 39: Trademark Registration Process, India, 2011 105Figure 40: Clinical Trial Approval Process, India, 2011 107Figure 41: GDP Per Capita ($), India, 20052010 116Figure 42: GDP Per Capita ($), India, Forecast, 20112020 117Figure 43: GDP, India, Annual Growth (%), 20062011 118Figure 44: GDP, India, Annual Growth (%), Forecast, 20122020 119Figure 45: GNI Per Capita ($), India, 20052010 120Figure 46: Average Consumer Price Index, India, 20062011 121Figure 47: Average Consumer Price Index, India, Forecast, 20122020 122Figure 48: Average Consumer Price, India, Annual Change (%), 20062011 123Figure 49: Average Consumer Price, India, Annual Change (%), Forecast, 20122020 124Figure 50: Currency Exchange Rate (INR/$), India, 20062011 125Figure 51: Foreign Direct Investment ($bn), India, 20052010 126Figure 52: Foreign Exchange Reserves ($bn), India, 20052010 127Figure 53: Imports of Goods and Services ($bn), India, 20052010 128Figure 54: Exports of Goods and Services ($bn), India, 20052010 129Figure 55: Gross Fiscal Deficits (% of GDP), India, 20052010 130Figure 56: External Government Gross Debt ($bn), India, 20052010 131Figure 57: Major Industries, India, GDP ($bn), 2010 133Figure 58: Population (m), India, 20062011 134Figure 59: Population (m), India, Forecast, 20122020 135Figure 60: Urban and Rural Population, India, Share (%), 20062011 136Figure 61: Age Groups, India, Population Distribution (%), 20062011 137Figure 62: Age Groups, India, Population Distribution (%), Forecast, 20122020 138Figure 63: Births (Per 1,000 Population), India, 20052010 139Figure 64: Mortality (Per 1,000 Population), India, 20052010 140Figure 65: Major Causes of Mortality ('000s), India, 2008 141Figure 66: Children <5 Years, India, Mortality Rate (Per 1,000 Live Births), 20052010 142>Figure 67: Immunization Rate (%), India, 20052010 143Figure 68: Major Causes of Male Mortality ('000s), India, 2008 144Figure 69: Major Causes of Female Mortality ('000s), India, 2008 145Figure 70: Gender Ratio (Females Per 1,000 Males), India, 20062011 146Figure 71: Life Expectancy at Birth (Years), India, 20052010 147Figure 72: Literacy Rate (%), India, 20062011 148Figure 73: Levels of Education, India, Students Enrollment (m), 2009 149Figure 74: Employees, India, Segment Share (%), 2010 150Figure 75: Major Communicable Diseases, Prevalence (Per 100,000 Population), India, 2010 151Figure 76: Major Diseases, India, DALY (Per 100,000 Population), 2004 152Figure 77: Public Hospitals, India, 20052010 153Figure 78: Health Centers ('000s), India, 20052010 156Figure 79: Hospitals by Bed Size, India, Share (%), 2010 157Figure 80: Public Hospital Beds ('000s), India, UrbanRural, 20052010 158Figure 81: Diagnostic Units (Per 100,000 Population), 2008 159Figure 82: Beds (Per 1,000 Population), India, 20052010 160Figure 83: Physicians (Per 100,000 Population), India, 20052010 161Figure 84: CO2 Emission (MMt), India, 20052010 162Figure 85: PM-10 Emissions (ตgm/cubic meter), India 20052010 163Figure 86: Waste Generation Per Capita (kg), India, 20052010 164Figure 87: Composition of Municipal Solid Waste (%), India, 2005 165Figure 88: Nurses (Per 100,000 Population), India, 20052010 166Figure 89: Pharmacists (Per 100,000 Population), India, 20052010 167Figure 90: Healthcare Expenditure (% of GDP), India, 20052010 168Figure 91: Healthcare Expenditure, India, Share of Major Components (%), 2005 169Figure 92: Healthcare Expenditure of Ministry of Health and Family Welfare, India, Share of Departments (%), 2008 170Figure 93: Pharmaceutical Expenditure (% of Total Healthcare Expenditure), India, 20052010 171Figure 94: Healthcare Expenditure, India, Share (%), 20052010 172Figure 95: R&D Expenditure ($m), India, 20052010 173Figure 96: Opportunities and Challenges, Healthcare Market, India, 2011 179
To order this report: Diagnostics Industry: Healthcare, Regulatory and Reimbursement Landscape - India
__________________________Contact Nicolas: [email protected] US: (805)-652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
